Bruker Biospin Corp

Bruker Biospin Corp, a subsidiary of Bruker Corporation headquartered in Billerica, Massachusetts, supplies nuclear magnetic resonance spectrometers, magnetic resonance imaging systems, electron paramagnetic resonance equipment, and related analytical instrumentation to federal agencies as a prime contractor, competing predominantly in full-and-open procurements with no set-aside designations.

Bruker Biospin Corp operates as a manufacturer of advanced scientific instrumentation across three core capability areas: NMR spectroscopy systems ranging from benchtop 400–900 MHz consoles to high-field 11.7 Tesla systems; preclinical and research MRI scanners (3T to 9.4T field strengths) with cryogenic probe systems and gradient coils; and electron spin resonance/electron paramagnetic resonance spectrometers. The company also delivers comprehensive maintenance agreements, helium and cryogenic services, equipment upgrades, and on-site repair services for installed systems. Representative recent prime awards include a $1.75 million National Institute of Diabetes and Digestive and Kidney Diseases purchase order (September 2026) for NMR cryoplatforms and Q-band EPR equipment with delivery to NIH Bethesda; a $2.91 million Naval Sea Systems Command contract (May 2025) for an AVANCE NMR spectrometer; and a $2.78 million National Institute of Biomedical Imaging and Bioengineering award (September 2024) for a high-field MRI scanner. Across all roles, Bruker Biospin Corp maintains service contracts valued in the hundreds of thousands with multiple NIH institutes, supporting critical research infrastructure through preventive maintenance and parts replacement.

Customer concentration is pronounced among civilian research and regulatory agencies. The top five customers by award count account for 30 percent of recent awards and include the National Institute on Drug Abuse (110 awards, $13.2 million combined potential value), the Food and Drug Administration (102 awards, $19.7 million), the Army (81 awards), the National Institute of Standards and Technology (62 awards, $15.8 million), and the Army Materiel Command Research Development and Engineering Command (57 awards, $6.2 million). When ranked by potential value, FDA leads at $19.7 million across 102 awards, followed closely by NIST and the National Institute of Diabetes and Digestive and Kidney Diseases (46 awards, $14 million). The vendor maintains active relationships with 99 distinct federal customer agencies, with NIH institutes collectively representing the largest customer segment. NAICS concentrations center on Analytical Laboratory Instrument Manufacturing (546 awards) and Electronic and Precision Equipment Repair and Maintenance (308 awards), aligned with the vendor's core business model of equipment procurement and ongoing support services.

Parent contract vehicles remain limited in the source data; Bruker Biospin Corp operates primarily on single-award and multiple-award purchase order and delivery-order contracts issued directly by agencies rather than through government-wide contract vehicles. The source identifies a handful of Army IDIQs (DAAA1594D0001 with 11 task orders, DAAD0585C4357 and DAAD0587C4079 each with 2 task orders) and a Basic Ordering Agreement (DAAD0587D0043) as active parent vehicles, but task-order volume on any single vehicle remains low, suggesting the vendor's federal footprint is anchored to direct transactional awards rather than large indefinite delivery contracts.

Recent activity has remained steady, with 40 awards in 2022, 51 in 2023, 46 in 2024, 28 in 2025, and 36 in 2026 to date. Awards completing in the next twenty-four months total 33 with combined potential value of $10.6 million, presenting moderate recompete opportunity for competitors. The vendor also operates as a subcontractor on a limited basis, with sub-awards documented to Ut-Battelle LLC (Oak Ridge National Laboratory NMR console support, June 2026), Leidos (explosives and munitions testing, 2025), Consolidated Nuclear Security (Y-12 and Pantex operations, 2024–2025), Honeywell Federal Manufacturing & Technologies (Kansas City National Security Campus, 2024), and Triad National Security (Los Alamos Laboratory equipment, 2024). Grant subaward activity includes a research partnership with the University of Denver (June 2024) on preclinical EPR imaging development under a Bruker BioSpin subcontract framework.

Bruker Biospin Corp competes exclusively in full-and-open competition with no recourse to small business set-asides; all awards in the source carry "No Set-Aside Used" designations. The vendor's market position rests on original equipment manufacturer status and proprietary technology—many awards explicitly note sole-source or non-competitive procurement justified by restricted access to replacement parts, diagnostic tools, factory-trained technicians, and warranty requirements. The company's federal contracting posture is transactional and relationship-driven: customers across NIH, FDA, DoD, and civilian research agencies award annual service agreements and equipment purchases directly to Bruker as the qualified provider, with minimal reliance on large government-wide vehicles or prime partnerships outside the defense laboratory ecosystem.